Almirall Sa Stock Net Income
| LBTSF Stock | USD 15.47 0.00 0.00% |
As of the 5th of February, Almirall shows the Mean Deviation of 0.4713, standard deviation of 1.94, and Risk Adjusted Performance of 0.0968. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Almirall, as well as the relationship between them. Please confirm Almirall SA variance and kurtosis to decide if Almirall SA is priced correctly, providing market reflects its regular price of 15.47 per share. Given that Almirall has variance of 3.78, we suggest you to validate Almirall SA's prevailing market performance to make sure the company can sustain itself at a future point.
Almirall's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Almirall's valuation are provided below:Almirall SA does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Almirall |
Almirall 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Almirall's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Almirall.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Almirall on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Almirall SA or generate 0.0% return on investment in Almirall over 90 days. Almirall is related to or competes with Dermapharm Holding, Sihuan Pharmaceutical, Curaleaf Holdings, CanSino Biologics, Fagron NV, Green Thumb, and Vitrolife. Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health ... More
Almirall Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Almirall's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Almirall SA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0899 | |||
| Maximum Drawdown | 15.79 |
Almirall Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Almirall's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Almirall's standard deviation. In reality, there are many statistical measures that can use Almirall historical prices to predict the future Almirall's volatility.| Risk Adjusted Performance | 0.0968 | |||
| Jensen Alpha | 0.233 | |||
| Total Risk Alpha | 0.0852 | |||
| Treynor Ratio | (3.40) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Almirall's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Almirall February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0968 | |||
| Market Risk Adjusted Performance | (3.39) | |||
| Mean Deviation | 0.4713 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 1.94 | |||
| Variance | 3.78 | |||
| Information Ratio | 0.0899 | |||
| Jensen Alpha | 0.233 | |||
| Total Risk Alpha | 0.0852 | |||
| Treynor Ratio | (3.40) | |||
| Maximum Drawdown | 15.79 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
Almirall SA Backtested Returns
Almirall appears to be not too volatile, given 3 months investment horizon. Almirall SA secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We have found sixteen technical indicators for Almirall SA, which you can use to evaluate the volatility of the firm. Please makes use of Almirall's Mean Deviation of 0.4713, standard deviation of 1.94, and Risk Adjusted Performance of 0.0968 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Almirall holds a performance score of 10. The firm shows a Beta (market volatility) of -0.0674, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Almirall are expected to decrease at a much lower rate. During the bear market, Almirall is likely to outperform the market. Please check Almirall's variance and kurtosis , to make a quick decision on whether Almirall's price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Almirall SA has no correlation between past and present. Overlapping area represents the amount of predictability between Almirall time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Almirall SA price movement. The serial correlation of 0.0 indicates that just 0.0% of current Almirall price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Almirall SA reported net income of (40.86 Million). This is 111.97% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 107.16% higher than that of the company.
Almirall Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Almirall's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Almirall could also be used in its relative valuation, which is a method of valuing Almirall by comparing valuation metrics of similar companies.Almirall is currently under evaluation in net income category among its peers.
Almirall Fundamentals
| Return On Equity | 0.0071 | |||
| Return On Asset | 0.0204 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.92 B | |||
| Shares Outstanding | 181.43 M | |||
| Shares Owned By Insiders | 59.60 % | |||
| Shares Owned By Institutions | 16.58 % | |||
| Price To Earning | 18.16 X | |||
| Price To Book | 1.23 X | |||
| Price To Sales | 2.03 X | |||
| Revenue | 827.2 M | |||
| Gross Profit | 645.59 M | |||
| EBITDA | 123.82 M | |||
| Net Income | (40.86 M) | |||
| Cash And Equivalents | 224.89 M | |||
| Cash Per Share | 1.29 X | |||
| Total Debt | 363.5 M | |||
| Debt To Equity | 0.29 % | |||
| Current Ratio | 2.22 X | |||
| Book Value Per Share | 7.38 X | |||
| Cash Flow From Operations | 233.85 M | |||
| Earnings Per Share | 0.17 X | |||
| Number Of Employees | 1.79 K | |||
| Beta | 0.35 | |||
| Market Capitalization | 1.76 B | |||
| Total Asset | 2.14 B | |||
| Working Capital | 405 M | |||
| Current Asset | 745 M | |||
| Current Liabilities | 340 M | |||
| Z Score | 2.4 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 2.14 B |
About Almirall Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Almirall SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Almirall using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Almirall SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Almirall Pink Sheet
Almirall financial ratios help investors to determine whether Almirall Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Almirall with respect to the benefits of owning Almirall security.